Laurencio Francis 4
4 · Atomera Inc · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Atomera (ATOM) CFO Laurencio Francis Receives Performance-Based Awards
What Happened
Laurencio Francis, Atomera’s Chief Financial Officer, was granted three performance-based derivative awards on March 11, 2026 totaling 157,776 units (78,888 + 39,444 + 39,444). Each award is shown on the Form 4 as acquired at $0.00 (derivative securities) and will only vest if specified average price (VWAP) hurdles are met within five years in addition to time-based vesting. The awards have staged vesting (first 25% on March 1, 2027; remaining 75% in 12 equal quarterly installments thereafter) but will terminate if the applicable VWAP threshold is not achieved within five years.
Key Details
- Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (appears timely). Transaction code: A (award/grant).
- Awards granted: 78,888 (Footnote F1), 39,444 (F2), 39,444 (F3) — total 157,776. Each line is a performance-based derivative award.
- VWAP price hurdles and vesting (per footnotes):
- F1 (78,888): 30-day VWAP must reach $20.00 within five years.
- F2 (39,444): 30-day VWAP must reach $7.50 within five years.
- F3 (39,444): 30-day VWAP must reach $12.50 within five years.
- Vesting schedule (all awards): 25% vests March 1, 2027; remaining 75% vests in 12 equal quarterly installments thereafter, but only if the applicable VWAP hurdle is met during the five-year window. If not met, awards terminate at five years.
- Price paid: $0.00 reported (derivative award); no immediate cash value listed in the filing.
- Shares owned after transaction: not specified in the provided summary of the filing.
Context
- These are conditional, performance-based derivative awards (options or similar) tied to both time and stock-price performance; they do not represent an open-market purchase of shares and may never vest if the price hurdles are not met.
- Such grants are typical for executive compensation and retention; they are not direct evidence of immediate buying or selling activity.
Insider Transaction Report
- Award
Performance Stock Option (right to buy)
[F1]2026-03-11+78,888→ 78,888 totalExercise: $5.10Exp: 2036-03-11→ Common Stock (78,888 underlying) - Award
Performance Stock Option (right to buy)
[F2]2026-03-11+39,444→ 39,444 totalExercise: $5.10Exp: 2036-03-11→ Common Stock (39,444 underlying) - Award
Performance Stock Option (right to buy)
[F3]2026-03-11+39,444→ 39,444 totalExercise: $5.10Exp: 2036-03-11→ Common Stock (39,444 underlying)
Footnotes (3)
- [F1]Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $20.00. In the event the $20.00 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
- [F2]Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $7.50. In the event the $7.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
- [F3]Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $12.50. In the event the $12.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.